Skip to main content
News Archive

Top 10 Companies Leveraging Gene Editing in 2019

By August 19, 2019May 22nd, 2025No Comments

dna-genes-pixa

Bayer made much of its desire to establish a cell therapy pipeline on August 8 when it announced it would shell out up to $600 million to acquire full control of BlueRock Therapeutics. But the deal is just the latest example of growing interest by biopharma giants in applying gene editing toward new treatments.

{iframe}https://www.genengnews.com/a-lists/top-10-companies-leveraging-gene-editing-in-2019/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20190815&oly_enc_id=5901D8426578G1Y{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.